A recent study published in the journal JAMA Pediatrics found that extremely low-birth-weight infants (ELBW) — that is, babies who are born with a birth weight of less than two pounds, three ounces — have a significantly higher risk of suffering severe adverse events or dying after being vaccinated. But curiously, the same paper that admits this also claims that it doesn’t admit this, encouraging doctors to jab underweight babies as normal!
Entitled “Adverse Events After Routine Immunization of Extremely Low-Birth-Weight Infants,” the study looked at nearly 14,000 ELBW infants born at 28 weeks’ gestation. Each of the babies was given at least one vaccination between the ages of 53 and 110 days, and researchers from the Duke University School of Medicine in North Carolina, the Greenville Hospital System in South Carolina, and the Pediatrix-Obstetrix Center for Research and Education in Florida evaluated the number of adverse events and deaths that resulted.
The team looked specifically at rates of sepsis evaluation post-vaccination, as well as how vaccines affect underweight babies’ need for respiratory support, intubation, seizures and death. Here’s what they found:
- Among the 91.2% of ELBW babies who received three or more vaccinations after birth, incidence of sepsis evaluations increased from 5.4 per 1,000 patient days in the pre-immunization period to 19.3 per 1,000 patient days in the post-immunization period. In other words, vaccinating ELBW babies resulted in a more than threefold increase in sepsis evaluations.
- The same group of babies experienced a more than twofold increase in the number of days required for respiratory support following vaccination, jumping from 6.6 per 1,000 patient days pre-immunization to 14.0 per 1,000 patient days post-immunization.
- Concerning intubation, ELBW babies who were vaccinated saw an increase from 2.0 per 1,000 patient days prior to the jabs to 3.6 per 1,000 patient days after getting the jabs, an increase of more than 55%.
“Immunization of extremely low-birth-weight (ELBW) infants in the neonatal intensive care unit (NICU) is associated with adverse events, including fever and apnea or bradycardia, in the immediate postimmunization period,” wrote the authors. “These adverse events present a diagnostic dilemma for physicians, leading to the potential for immunization delay and sepsis evaluations.”